Session VII: Acute Leukemia - Part II
Tracks
Plenary Hall
Saturday, October 12, 2024 |
12:15 PM - 1:25 PM |
Speaker
Dr. Adil Al Hinai
Molecular Lab Incharge and deputy of Head of Genetic Laboratories
The Royal Hospital
Value of NGS as MRD tool in AML
12:15 PM - 12:35 PM
Dr. Zeyad Al Shaibani
Section Head Hematology and Blood and Bone Marrow Transplant
King Faisal Specialist Hospital
Maintenance therapy for Acute Leukemia post HSCT
12:35 PM - 12:55 PM
Dr. Murtadha Al Khabori
Senior Consultant Hematologist
Sultan Qaboos University Hospital
Incorporation of novel therapy in the upfront management of ALL
12:55 PM - 1:15 PMSession Chair
Thuraya Al Busaidi
Consultant Hematologist
Sultan Qaboos University Hospital
Murtadha Al Khabori
Senior Consultant Hematologist
Sultan Qaboos University Hospital